Science Explorer Back to mapMap
Discussion
Company · San Diego · United States

Arena Pharmaceuticals (United States)

World rank, all time
#31,280
of 34,923
Rank in United States
#6,619
of 7,310
Research works
237
▼ 40% vs 2018-21
Citations
11k
47.2 per fractional work
Top-10% rate
9.8%
all institutions 10.0%
vs its own fields
0.98×
1.00× is exactly expected
Open access
39%
world 40%
International
17%
world 18%

Which fields of science does Arena Pharmaceuticals (United States) work in?

In 2022-now, 39% of research at Arena Pharmaceuticals (United States) is in Health Sciences, 22% in Life Sciences. Its largest fields are Medicine (38%), Social Sciences (13%), Biochemistry, Genetics and Molecular Biology (10%). It does 1.5× the world's share of Health Sciences.

Health Sciences: 10 fractional works · 39.2% of its workMedicine: 9 fractional works · 37.8% of its workSurgery: 1 fractional works · 5.0% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.4% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 4.2% of its workPulmonary and Respiratory Medicine: 1 fractional works · 4.1% of its workHematology: 1 fractional works · 3.6% of its workReproductive Medicine: 1 fractional works · 3.2% of its workRheumatology: 1 fractional works · 2.9% of its workPathology and Forensic Medicine: 1 fractional works · 2.1% of its workDermatology: 0 fractional works · 2.0% of its workEpidemiology: 0 fractional works · 1.7% of its workOncology: 0 fractional works · 1.1% of its workPharmacology: 0 fractional works · 1.1% of its workGenetics: 0 fractional works · 1.0% of its workGastroenterology: 0 fractional works · 0.5% of its workHepatology: 0 fractional works · 0.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 1.4% of its workGeneral Health Professions: 0 fractional works · 1.4% of its workLife Sciences: 5 fractional works · 22.4% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 10.4% of its workMolecular Biology: 2 fractional works · 7.3% of its workGenetics: 0 fractional works · 1.7% of its workBiotechnology: 0 fractional works · 0.8% of its workCancer Research: 0 fractional works · 0.7% of its workImmunology and Microbiology: 1 fractional works · 6.0% of its workImmunology: 1 fractional works · 6.0% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.7% of its workPharmacology: 1 fractional works · 2.7% of its workAgricultural and Biological Sciences: 0 fractional works · 1.8% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 1.4% of its workPlant Science: 0 fractional works · 0.5% of its workNeuroscience: 0 fractional works · 1.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.1% of its workCognitive Neuroscience: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 5 fractional works · 22.2% of its workSocial Sciences: 3 fractional works · 13.3% of its workPolitical Science and International Relations: 2 fractional works · 6.4% of its workEducation: 1 fractional works · 3.8% of its workHealth: 0 fractional works · 1.6% of its workLaw: 0 fractional works · 0.7% of its workGeneral Social Sciences: 0 fractional works · 0.2% of its workSociology and Political Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 2 fractional works · 6.8% of its workEconomics and Econometrics: 1 fractional works · 4.1% of its workGeneral Economics, Econometrics and Finance: 1 fractional works · 2.7% of its workBusiness, Management and Accounting: 0 fractional works · 1.4% of its workBusiness and International Management: 0 fractional works · 1.4% of its workArts and Humanities: 0 fractional works · 0.7% of its workArcheology: 0 fractional works · 0.3% of its workHistory: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysical Sciences: 4 fractional works · 16.2% of its workComputer Science: 2 fractional works · 7.7% of its workArtificial Intelligence: 1 fractional works · 2.9% of its workInformation Systems: 0 fractional works · 2.0% of its workComputer Networks and Communications: 0 fractional works · 1.4% of its workComputer Vision and Pattern Recognition: 0 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workChemistry: 1 fractional works · 4.0% of its workOrganic Chemistry: 1 fractional works · 4.0% of its workEngineering: 1 fractional works · 2.1% of its workElectrical and Electronic Engineering: 0 fractional works · 1.4% of its workBiomedical Engineering: 0 fractional works · 0.7% of its workMaterials Science: 0 fractional works · 1.4% of its workMaterials Chemistry: 0 fractional works · 1.4% of its workMathematics: 0 fractional works · 0.5% of its workAlgebra and Number Theory: 0 fractional works · 0.5% of its workEnergy: 0 fractional works · 0.3% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.0% of its workALL ITS WORKArenaPharmaceuticals…24fractional works, 2022-now
Life Sciences22%Physical Sciences16%Health Sciences39%Social Sciences22%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine937.8%
    2. Health Professions01.4%
    1. Biochemistry, Genetics and Molecular Biology310.4%
    2. Immunology and Microbiology16.0%
    3. Pharmacology, Toxicology and Pharmaceutics12.7%
    4. Agricultural and Biological Sciences01.8%
    5. Neuroscience01.6%
    1. Social Sciences313.3%
    2. Economics, Econometrics and Finance26.8%
    3. Business, Management and Accounting01.4%
    4. Arts and Humanities00.7%
    1. Computer Science27.7%
    2. Chemistry14.0%
    3. Engineering12.1%
    4. Materials Science01.4%
    5. Mathematics00.5%
    6. Energy00.3%
    7. Environmental Science00.2%
    8. Earth and Planetary Sciences00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.38× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.96× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 5.94× its world share, 2 worksImmunology and Micro…Neuroscience: 0.96× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.53× its world share, 1 worksPharmacology, Toxico…Chemistry: 2.54× its world share, 1 worksChemistryComputer Science: 0.99× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.02× its world share, 0 worksEarth and Planetary …Energy: 0.37× its world share, 0 worksEnergyEngineering: 0.14× its world share, 0 worksEngineeringEnvironmental Science: 0.04× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.39× its world share, 0 worksMaterials ScienceMathematics: 0.39× its world share, 0 worksMathematicsHealth Professions: 0.52× its world share, 0 worksHealth ProfessionsMedicine: 1.97× its world share, 9 worksMedicineArts and Humanities: 0.24× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.42× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 3.19× its world share, 2 worksEconomics, Econometr…Social Sciences: 1.05× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.5×. Every wedge is a field page.

All 19 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics7.53×1 works
  2. Immunology and Microbiology5.94×2 works
  3. Economics, Econometrics and Finance3.19×2 works
  4. Chemistry2.54×1 works
  5. Medicine1.97×9 works
  6. Biochemistry, Genetics and Molecular Biology1.96×2 works
  7. Social Sciences1.05×3 works
  8. Computer Science0.99×2 works
  9. Neuroscience0.96×0 works
  10. Health Professions0.52×0 works
  11. Business, Management and Accounting0.42×0 works
  12. Materials Science0.39×0 works
  13. Mathematics0.39×0 works
  14. Agricultural and Biological Sciences0.38×0 works
  15. Energy0.37×0 works
  16. Arts and Humanities0.24×0 works
  17. Engineering0.14×0 works
  18. Environmental Science0.04×0 works
  19. Earth and Planetary Sciences0.02×0 works

Who are the top researchers at Arena Pharmaceuticals (United States)?

Ranked on the quality score, Daniel T. Connolly, Michael E. Morgan and Dominic P. Behan lead among researchers whose main affiliation is Arena Pharmaceuticals (United States).

  1. 1 Daniel T. Connolly United States · #417,902 worldwide 10k citations · 63 works
  2. 2 Michael E. Morgan United States · #718,259 worldwide 4.3k citations · 93 works
  3. 3 Dominic P. Behan United States · #771,853 worldwide 5.7k citations · 76 works
  4. 4 Christen M. Anderson United States · #869,752 worldwide 4.4k citations · 32 works
  5. 5 Albert Ren United States · #1,179,932 worldwide 2.1k citations · 45 works
  6. 6 Ibragim Gaidarov United States · #1,489,654 worldwide 3.3k citations · 41 works
  7. 7 Zhi‐Liang Chu United States · #1,529,932 worldwide 2.6k citations · 24 works
  8. 8 Matilde Sanchez United States · #1,587,364 worldwide 2.7k citations · 18 works
  9. 9 Brian M. Smith United States · #1,603,422 worldwide 2.1k citations · 30 works
  10. 10 John S. Grundy United States · #1,711,745 worldwide 2k citations · 58 works
All ranked researchers at Arena Pharmaceuticals (United States)

What are the most cited papers from Arena Pharmaceuticals (United States)?

The most cited paper from Arena Pharmaceuticals (United States) is "Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group" (Claudio Vitali, S Bombardieri, R Jonsson et al., 2002), with 5,366 citations. Next come "Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management" (912) and "A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)" (722).

Most cited papers
#PaperReleasedCitations
1 Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group Claudio Vitali, S Bombardieri, R Jonsson et al. · Annals of the Rheumatic Diseases Open access Jun 2002 5,366
2 Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management Steven R. Smith, Neil J. Weissman, Christen M. Anderson et al. · New England Journal of Medicine Open access 14 Jul 2010 912
3 A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II) Caroline M. Apovian, Louis J. Aronne, Domenica Rubino et al. · Obesity Open access 14 Feb 2013 722
4 Regulation of Serotonin1A, Glucocorticoid, and Mineralocorticoid Receptor in Rat and Human Hippocampus: Implications for the Neurobiology of Depression Juan F. López, Derek T. Chalmers, Karley Y. Little et al. · Biological Psychiatry Apr 1998 703
5 (d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G Andrew K.P. Taggart, Jukka Kero, Xiaodong Gan et al. · Journal of Biological Chemistry Open access Jun 2005 660
All 60 most cited papers, with filters and sorting

Which keywords describe research at Arena Pharmaceuticals (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Management, Diagnosis, Insulin Resistance, Fertility, Gender, Epidemiology, Nazi Propaganda and Sexuality.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 8 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 8 words, with their numbers
  1. Epidemiology2▲ 2.1×9 topics
  2. Diagnosis2▲ 6.8×5 topics
  3. Management2▲ 7.8×5 topics
  4. Insulin Resistance1▲ 13×2 topics
  5. Fertility1▲ 63×2 topics
  6. Gender1▲ 8.2×2 topics
  7. Nazi Propaganda1▲ 224×1 topic
  8. Sexuality1▲ 56×1 topic

Which research topics does Arena Pharmaceuticals (United States) publish most on?

By volume in 2022-now: European history and politics, Monoclonal and Polyclonal Antibodies Research, Sphingolipid Metabolism and Signaling and Eosinophilic Esophagitis.

  1. 1 European history and politics Political Science and International Relations 1 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Sphingolipid Metabolism and Signaling Molecular Biology 1 works
  4. 4 Eosinophilic Esophagitis Surgery 1 works
  5. 5 Pregnancy and Medication Impact Public Health, Environmental and Occupational Health 1 works
  6. 6 Ovarian function and disorders Reproductive Medicine 1 works
  7. 7 Pharmacogenetics and Drug Metabolism Pharmacology 1 works
  8. 8 Click Chemistry and Applications Organic Chemistry 1 works
  9. 9 Chronic Myeloid Leukemia Treatments Hematology 0 works
  10. 10 Reproductive System and Pregnancy Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.0%not open61.0%

World: 40% of research is openly available.

with international co-authors17.0%domestic only83.0%

World: 18% is written across borders.

How has Arena Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 40% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Arena Pharmaceuticals (United States) as a percentage of every work published that year, 0.000045% in 2024.

still counting0.00025%0.00050%0.00075%Arena Pharmaceuticals (United States)0.000056% in 202519801990200020102020

Fractional works of Arena Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in San Diego

All research institutions in San Diego

Share Arena Pharmaceuticals (United States)'s ranking

Arena Pharmaceuticals (United States) on Science Explorer

A card with Arena Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Arena Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.